Ubamatamab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Ubamatamab, covering 2025-11-21 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer [Phase 2]